ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,801Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 288

$818K Total Retail Price of All Prescriptions

Rank: 10 out of 288

675 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 675 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 675 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 17,161 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 1,264 1,093 1 1
LISINOPRIL 1,160 1,016 2 4
LEVOTHYROXINE SODIUM 877 733 3 2
OMEPRAZOLE 812 687 4 3
FUROSEMIDE 749 651 5 5
METFORMIN HCL 539 434 6 12
METOPROLOL TARTRATE 530 437 7 8
AMLODIPINE BESYLATE 503 447 8 6
ATENOLOL 468 428 9 10
HYDROCHLOROTHIAZIDE 416 373 10 13
HYDROCODONE-ACETAMINOPHEN 408 285 S3 11 7
WARFARIN SODIUM 407 347 12 9
GABAPENTIN 342 230 13 17
GLIMEPIRIDE 326 286 14 32
PRAVASTATIN SODIUM 322 277 15 21
LOSARTAN POTASSIUM 300 275 16 16
METOPROLOL SUCCINATE 277 232 17 15
KLOR-CON 10 274 254 18 66
POTASSIUM CHLORIDE 272 259 19 11
LANTUS 248 178 20 31
TAMSULOSIN HCL 241 219 21 24
CITALOPRAM HBR 198 180 22 18
CARVEDILOL 188 163 23 27
ALLOPURINOL 184 140 24 23
ALENDRONATE SODIUM 181 172 25 20
CRESTOR 173 127 26 26
ATORVASTATIN CALCIUM 168 128 27 14
CYMBALTA 150 128 28 67
SPIRONOLACTONE 147 133 29 36
AZITHROMYCIN 135 111 30 49
PREDNISONE 134 128 31 30
PANTOPRAZOLE SODIUM 131 130 32 42
POLYETHYLENE GLYCOL 3350 131 118 32 38
TRAMADOL HCL 127 91 34 19
GLIPIZIDE 124 99 35 56
ZOLPIDEM TARTRATE 124 97 35 22
PROAIR HFA 121 81 37 45
SERTRALINE HCL 119 95 38 25
LOSARTAN-HYDROCHLOROTHIAZIDE 115 90 39 55
CLOPIDOGREL 113 91 40 47
ISOSORBIDE MONONITRATE ER 112 108 41 35
OXYCODONE-ACETAMINOPHEN 111 101 S2 42 109
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 102 42 34
DETROL LA 108 71 44 162
ROPINIROLE HCL 105 99 45 74
OXYBUTYNIN CHLORIDE 104 93 46 69
FLUOXETINE HCL 101 76 47 64
ADVAIR DISKUS 96 77 48 50
CIPROFLOXACIN HCL 94 78 49 62
FAMOTIDINE 93 57 50 68
BENAZEPRIL HCL 91 87 51 52
FLUTICASONE PROPIONATE 90 60 52 41
PLAVIX 88 74 53 71
SPIRIVA 83 52 54 48
DONEPEZIL HCL 81 81 55 29
DIGOXIN 79 59 56 51
LANTUS SOLOSTAR 77 73 57 81
FENTANYL 77 76 S2 57 57
DILTIAZEM ER 76 75 59 102
ENALAPRIL MALEATE 74 60 60 40
RANITIDINE HCL 73 50 61 33
RISPERIDONE 72 60 62 98
AGGRENOX 72 63 62 136
NAMENDA 71 71 64 39
ESCITALOPRAM OXALATE 70 61 65 87
INSULIN SYRINGE 69 14 66 79
DILTIAZEM 24HR CD 68 48 67 75
GLYBURIDE 66 51 R 68 59
TERAZOSIN HCL 64 55 69 85
ZETIA 62 53 70 58
NEXIUM 62 45 70 43
SYNTHROID 60 60 72 63
AMITRIPTYLINE HCL 60 60 R 72 65
LYRICA 57 42 74 114
NYSTOP 57 39 74 220
LEXAPRO 57 51 74 279
LOVASTATIN 57 33 74 46
PAROXETINE HCL 55 39 78 54
TRAZODONE HCL 54 16 79 37
NIASPAN 53 13 80 103
IPRATROPIUM-ALBUTEROL 51 51 81 99
GLIPIZIDE ER 50 50 82 93
AMOX TR-POTASSIUM CLAVULANATE 50 36 82 212
DIOVAN 50 43 82 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.